The impaired USP44-TRIM25-KU80 axis is supposed to act as a major pathway of resistance of NPC and probably other human cancers towards ionizing radiation, and therefore, offers an attractive target for novel resensitizing tumor therapies. Here, TRIM25 is linked to nasopharyngeal carcinoma.